216 related articles for article (PubMed ID: 27736845)
1. IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma.
Matsuoka Y; Nakayama H; Yoshida R; Hirosue A; Nagata M; Tanaka T; Kawahara K; Sakata J; Arita H; Nakashima H; Shinriki S; Fukuma D; Ogi H; Hiraki A; Shinohara M; Toya R; Murakami R
Br J Cancer; 2016 Nov; 115(10):1234-1244. PubMed ID: 27736845
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells-derived IL-6 promotes invasion and metastasis of oral squamous cell carcinoma via JAK-STAT3 signalling.
Liu C; Zhou J; Zhang S; Fu J; Li Y; Hao Y; Yuan J; Tang F; Ge W; He H; Chen Q
Oral Dis; 2024 May; 30(4):2097-2109. PubMed ID: 37249062
[TBL] [Abstract][Full Text] [Related]
3. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y
Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815
[TBL] [Abstract][Full Text] [Related]
4. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
5. The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation.
Matsuoka Y; Yoshida R; Kawahara K; Sakata J; Arita H; Nkashima H; Takahashi N; Hirayama M; Nagata M; Hirosue A; Kuwahara Y; Fukumoto M; Toya R; Murakami R; Nakayama H
Lab Invest; 2022 Aug; 102(8):896-907. PubMed ID: 35414650
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo.
Zhang X; Su Y; Zhang M; Sun Z
Cancer Lett; 2012 May; 318(1):93-8. PubMed ID: 22155346
[TBL] [Abstract][Full Text] [Related]
7. 2-O-Methylmagnolol Induces Apoptosis and Inhibits IL-6/STAT3 Signaling in Oral Squamous Cell Carcinoma.
Wang TH; Fang JY; Wu SJ; Liu YW; Chan CW; Chuang SY; Chen CY
Cell Physiol Biochem; 2018; 50(3):883-892. PubMed ID: 30355952
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase-2 (PON2) protects oral squamous cell cancer cells against irradiation-induced apoptosis.
Krüger M; Pabst AM; Al-Nawas B; Horke S; Moergel M
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1757-66. PubMed ID: 25708945
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.
Kurago ZB; Lam-ubol A; Stetsenko A; De La Mater C; Chen Y; Dawson DV
Head Neck Pathol; 2008 Mar; 2(1):1-12. PubMed ID: 19603082
[TBL] [Abstract][Full Text] [Related]
10. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer.
Kruser TJ; Armstrong EA; Ghia AJ; Huang S; Wheeler DL; Radinsky R; Freeman DJ; Harari PM
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):534-42. PubMed ID: 18793955
[TBL] [Abstract][Full Text] [Related]
12. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
Li X; Ding R; Han Z; Ma Z; Wang Y
Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
[TBL] [Abstract][Full Text] [Related]
13. Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.
Sun HB; Zheng HY; Yan X
Eur Rev Med Pharmacol Sci; 2014; 18(18):2678-86. PubMed ID: 25317803
[TBL] [Abstract][Full Text] [Related]
14. Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling.
Yang JG; Lu R; Ye XJ; Zhang J; Tan YQ; Zhou G
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085115
[TBL] [Abstract][Full Text] [Related]
15. ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma.
Yun MR; Choi HM; Kang HN; Lee Y; Joo HS; Kim DH; Kim HR; Hong MH; Yoon SO; Cho BC
Oncogene; 2018 Jan; 37(3):377-388. PubMed ID: 28945228
[TBL] [Abstract][Full Text] [Related]
16. STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma.
Naher L; Kiyoshima T; Kobayashi I; Wada H; Nagata K; Fujiwara H; Ookuma YF; Ozeki S; Nakamura S; Sakai H
Int J Oncol; 2012 Nov; 41(5):1577-86. PubMed ID: 22922995
[TBL] [Abstract][Full Text] [Related]
17. Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor.
Chen CC; Chen WC; Lu CH; Wang WH; Lin PY; Lee KD; Chen MF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1214-24. PubMed ID: 20206020
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 regulates cellular behaviors and Notch signaling in oral squamous cell carcinoma cells.
Fan H; Paiboonrungruan C; Zhang X; Prigge JR; Schmidt EE; Sun Z; Chen X
Biochem Biophys Res Commun; 2017 Nov; 493(1):833-839. PubMed ID: 28821430
[TBL] [Abstract][Full Text] [Related]
19. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
20. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
